Brief: Microba Life Sciences Logs Qtrly Total Revenue A$3.36 Mln
30/04/2026 02:51
April 30 (Reuters) - Microba Life Sciences Ltd MAP.AX: Q3 FY26 TOTAL REVENUE OF A$3.36M Further company coverage: MAP.AX ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Microba Life Sciences
See all newsBrief: Genetic Signatures Says Microba Shareholders To Hold 60% Of GSS On Merger
Brief: Microba Life Sciences Announces Placement Via Two Tranches
Brief: Microba Life Sciences Appoints Geoffrey Cockerill As Interim CEO
Australia's Genetic Signatures climbs on potential merger with Microba
Brief: Microba Life Sciences Says Microba Signs Multi-Year Synlab Agreement